nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—HTR1A—migraine	0.585	1	CbGaD
Lofexidine—HTR1A—Propranolol—migraine	0.132	0.371	CbGbCtD
Lofexidine—HTR1A—Amitriptyline—migraine	0.114	0.321	CbGbCtD
Lofexidine—ADRA2A—Amitriptyline—migraine	0.109	0.307	CbGbCtD
Lofexidine—HTR1A—Serotonin receptors—HTR1D—migraine	0.00403	0.0661	CbGpPWpGaD
Lofexidine—HTR1A—Serotonin receptors—HTR2B—migraine	0.00375	0.0614	CbGpPWpGaD
Lofexidine—HTR1A—Serotonin receptors—HTR1B—migraine	0.00244	0.04	CbGpPWpGaD
Lofexidine—HTR1A—Serotonin receptors—HTR2C—migraine	0.00227	0.0372	CbGpPWpGaD
Lofexidine—HTR1A—Serotonin receptors—HTR7—migraine	0.00199	0.0326	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—HTR1D—migraine	0.00179	0.0294	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—HTR2B—migraine	0.00167	0.0274	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—HTR1D—migraine	0.00151	0.0247	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR1D—migraine	0.00141	0.0231	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—HTR2B—migraine	0.0014	0.023	CbGpPWpGaD
Lofexidine—HTR1A—Serotonin receptors—HTR2A—migraine	0.00139	0.0228	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR2B—migraine	0.00131	0.0215	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR1D—migraine	0.00119	0.0194	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR2B—migraine	0.0011	0.0181	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—HTR1B—migraine	0.00109	0.0178	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—HTR2C—migraine	0.00101	0.0166	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—HTR1B—migraine	0.000914	0.015	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—HTR7—migraine	0.000885	0.0145	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR1B—migraine	0.000855	0.014	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—HTR2C—migraine	0.00085	0.0139	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR1A—migraine	0.000823	0.0135	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR2C—migraine	0.000795	0.013	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000747	0.0123	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—CACNA1A—migraine	0.000747	0.0122	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—HTR7—migraine	0.000744	0.0122	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR1B—migraine	0.000718	0.0118	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR7—migraine	0.000696	0.0114	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR1A—migraine	0.000692	0.0113	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR2C—migraine	0.000668	0.0109	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—HTR3A—migraine	0.000635	0.0104	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—HTR2A—migraine	0.00062	0.0102	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—CACNA1A—migraine	0.000587	0.00963	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR7—migraine	0.000585	0.00959	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—HTR2A—migraine	0.000521	0.00855	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—HTR2A—migraine	0.000487	0.00799	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—HTR2A—migraine	0.00041	0.00672	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—HTR1D—migraine	0.000373	0.00612	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000346	0.00568	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000322	0.00528	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—RAMP1—migraine	0.000311	0.0051	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CALCRL—migraine	0.000311	0.0051	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TAC1—migraine	0.000298	0.00488	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000297	0.00487	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—HTR1D—migraine	0.000293	0.00481	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000292	0.00478	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000276	0.00452	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000272	0.00446	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000253	0.00415	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CALCRL—migraine	0.000244	0.00401	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—RAMP1—migraine	0.000244	0.00401	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000233	0.00382	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—HTR1B—migraine	0.000226	0.00371	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR1D—migraine	0.000226	0.0037	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000217	0.00355	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—BDNF—migraine	0.000212	0.00347	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR2B—migraine	0.00021	0.00344	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00021	0.00344	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000195	0.0032	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00019	0.00311	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00018	0.00295	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—HTR2A—migraine	0.000179	0.00293	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—HTR1B—migraine	0.000178	0.00291	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR1D—migraine	0.000178	0.00291	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—RAMP1—migraine	0.000176	0.00288	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CALCRL—migraine	0.000176	0.00288	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—HTR1A—migraine	0.000171	0.0028	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000171	0.0028	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00017	0.00279	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00017	0.00279	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000167	0.00274	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR2B—migraine	0.000165	0.00271	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000165	0.0027	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000163	0.00267	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—RAMP1—migraine	0.00016	0.00262	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CALCRL—migraine	0.00016	0.00262	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000159	0.0026	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000153	0.00251	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000149	0.00245	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000146	0.0024	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000141	0.00232	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—RAMP1—migraine	0.000138	0.00226	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CALCRL—migraine	0.000138	0.00226	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR1B—migraine	0.000137	0.00224	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000136	0.00223	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000134	0.0022	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000134	0.0022	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000134	0.0022	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000131	0.00215	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—TAC1—migraine	0.00013	0.00213	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—NPS—migraine	0.00013	0.00213	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000128	0.0021	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR1D—migraine	0.000128	0.00209	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR2C—migraine	0.000127	0.00209	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—RAMP1—migraine	0.000125	0.00206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CALCRL—migraine	0.000125	0.00206	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—EDNRA—migraine	0.000124	0.00203	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00012	0.00196	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CALCA—migraine	0.000119	0.00195	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2B—migraine	0.000119	0.00195	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR1D—migraine	0.000116	0.0019	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000115	0.00189	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR7—migraine	0.000111	0.00183	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2B—migraine	0.000108	0.00177	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR1B—migraine	0.000108	0.00176	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR1A—migraine	0.000104	0.0017	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000103	0.00168	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—TAC1—migraine	0.000102	0.00167	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—NPS—migraine	0.000102	0.00167	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	0.0001	0.00165	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR2C—migraine	0.0001	0.00164	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—EDNRA—migraine	9.73e-05	0.0016	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RAMP1—migraine	9.43e-05	0.00155	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CALCRL—migraine	9.43e-05	0.00155	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.41e-05	0.00154	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CALCA—migraine	9.37e-05	0.00154	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	9.33e-05	0.00153	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR1D—migraine	9.12e-05	0.00149	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR7—migraine	8.76e-05	0.00144	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2B—migraine	8.47e-05	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.06e-05	0.00132	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—HTR2A—migraine	7.81e-05	0.00128	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR1B—migraine	7.74e-05	0.00127	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TNF—migraine	7.7e-05	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RAMP1—migraine	7.41e-05	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CALCRL—migraine	7.41e-05	0.00121	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—TAC1—migraine	7.34e-05	0.0012	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—NPS—migraine	7.34e-05	0.0012	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2C—migraine	7.19e-05	0.00118	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR1B—migraine	7.03e-05	0.00115	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—EDNRA—migraine	7e-05	0.00115	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR1D—migraine	6.85e-05	0.00112	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CALCA—migraine	6.74e-05	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CACNA1A—migraine	6.72e-05	0.0011	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—TAC1—migraine	6.66e-05	0.00109	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—NPS—migraine	6.66e-05	0.00109	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2C—migraine	6.53e-05	0.00107	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2B—migraine	6.37e-05	0.00104	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EDNRA—migraine	6.35e-05	0.00104	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR7—migraine	6.3e-05	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—HTR2A—migraine	6.14e-05	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CALCA—migraine	6.12e-05	0.001	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	6.08e-05	0.000997	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	5.85e-05	0.00096	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—NPS—migraine	5.77e-05	0.000945	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—TAC1—migraine	5.77e-05	0.000945	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR7—migraine	5.72e-05	0.000938	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	5.65e-05	0.000927	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LRP1—migraine	5.61e-05	0.000919	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR1B—migraine	5.52e-05	0.000905	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	5.5e-05	0.000902	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR1D—migraine	5.38e-05	0.000883	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR1A—migraine	5.32e-05	0.000871	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CALCA—migraine	5.29e-05	0.000868	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—TAC1—migraine	5.24e-05	0.000858	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NPS—migraine	5.24e-05	0.000858	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2C—migraine	5.13e-05	0.000842	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2B—migraine	5.01e-05	0.000821	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EDNRA—migraine	4.99e-05	0.000819	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR7—migraine	4.95e-05	0.000812	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CALCA—migraine	4.81e-05	0.000788	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR7—migraine	4.5e-05	0.000737	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2A—migraine	4.41e-05	0.000723	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LRP1—migraine	4.41e-05	0.000723	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH4—migraine	4.3e-05	0.000705	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR1B—migraine	4.15e-05	0.00068	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2A—migraine	4.01e-05	0.000657	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NPS—migraine	3.93e-05	0.000645	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PGR—migraine	3.93e-05	0.000645	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TAC1—migraine	3.93e-05	0.000645	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2C—migraine	3.86e-05	0.000633	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EDNRA—migraine	3.75e-05	0.000615	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOTCH3—migraine	3.66e-05	0.0006	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CALCA—migraine	3.61e-05	0.000592	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	3.47e-05	0.000569	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH4—migraine	3.38e-05	0.000554	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR7—migraine	3.38e-05	0.000554	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR1B—migraine	3.26e-05	0.000535	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2A—migraine	3.15e-05	0.000516	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR1A—migraine	3.14e-05	0.000515	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TAC1—migraine	3.09e-05	0.000507	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NPS—migraine	3.09e-05	0.000507	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PGR—migraine	3.09e-05	0.000507	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2C—migraine	3.03e-05	0.000497	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDNRA—migraine	2.95e-05	0.000484	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFBR2—migraine	2.91e-05	0.000477	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOTCH3—migraine	2.88e-05	0.000471	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CALCA—migraine	2.84e-05	0.000466	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR7—migraine	2.66e-05	0.000435	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2A—migraine	2.37e-05	0.000388	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFBR2—migraine	2.29e-05	0.000375	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—migraine	2.22e-05	0.000364	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—migraine	2.1e-05	0.000344	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2A—migraine	1.86e-05	0.000305	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—migraine	1.65e-05	0.000271	CbGpPWpGaD
